- $2.03bn
- $2.09bn
- $510.17m
U.S. STOCKS ON THE MOVE-Rivian, Crypto stocks, Canoo
ADMA Biologics rises on upbeat Q3 revenue; raises FY revenue forecast
Adma Biologics Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: Adma Biologics Announces Third Quarter 2022 Financial Results
Adma Biologics Inc Expected To Post A Loss Of 8 Cents A Share: Earnings Preview
Brief: Adma Biocenters Receives FDA Approval For Its Seventh Plasma Collection Center
U.S. RESEARCH ROUNDUP-Abiomed, McDonald's, S&P Global
Brief: Adma Biologics Announces Second Quarter 2022 Financial Results And Provides Business Update
Adma Biologics Inc Reports Results For The Quarter Ended In June: Earnings Summary
Adma Biologics Inc Expected To Post A Loss Of 8 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Virgin Orbit, ETSY, Coinbase, Peloton
U.S. STOCKS ON THE MOVE-Robinhood, Spirit Airlines, Polestar, Axsome Therapeutics
U.S. STOCKS ON THE MOVE-Digital World Acquisition, Polestar, Chinese ADRs
ADMA Biologics rises after FDA approves sixth plasma collection center
Brief: Adma Biologics Inc - Company Is On-Track To Have All 10 Plasma Collection Centers FDA-Approved By Year-End 2023
Brief: Adma Biologics Announces Addition To The Russell 2000 Index
U.S. STOCKS ON THE MOVE-Rivian, Walt Disney, Beyond Meat, Apple
ADMA Biologics jumps on revenue beat, upbeat FY outlook
Adma Biologics Inc Reports Results For The Quarter Ended In March: Earnings Summary